Used primarily in the management of type 2 diabetes mellitus, this compound helps control blood glucose levels by stimulating insulin release from the pancreas. It belongs to the sulfonylurea class of drugs, which act by closing ATP-sensitive potassium channels in pancreatic beta cells, leading to cell depolarization and subsequent insulin secretion. It is typically prescribed when diet and exercise alone are insufficient for glucose control. Due to its moderate duration of action, it is often taken one to two times daily. It may also be used off-label in certain cases of neonatal diabetes caused by specific genetic mutations affecting potassium channels. Its use requires monitoring for hypoglycemia, especially in elderly patients or those with irregular meal patterns.